Cutaneous metastases occur when malignant cells from internal tumours disseminate to the skin, typically via haematogenous or lymphatic routes. Although relatively uncommon, with incidence varying ...
The FDA has granted Fast Track designation to dubodencel (DOC1021) for unresectable or metastatic cutaneous melanoma. The ...
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, announced today that the U.S. Food and Drug ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the pivotal Phase 3 MK-3475A-D77 trial. The trial ...
C5aR1 expression correlates with increased metastasis risk and poor survival in cSCC patients. The tumor microenvironment, especially fibroblasts, influences C5aR1 expression and cSCC progression.
An international consortium of leading cancer centers and SkylineDx has put together a comprehensive data resource to characterize the genomic and transcriptomic landscape of cutaneous squamous ...
Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM). This is an ASCO Meeting Abstract from ...
Fast Track status aims to accelerate development of an autologous dendritic cell immunotherapy for advanced cutaneous ...
Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results